Physician profile
Taylor H Tang
NPI 1851611354
$22,881.29
in general payments reported to CMS, 2019-2025
28 companies · $3,990 in 2025
The $3,990 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,643 · 2020: $2,301 · 2021: $1,225 · 2022: $2,987 · 2023: $3,340 · 2024: $6,396 · 2025: $3,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $2,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,575.57 |
| Consulting Fee | $2,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,305.76 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $4,532.74 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Abiomed | $3,523.43 | 2019-2025 | Impella |
| Abbott Laboratories | $2,131.10 | 2019-2024 | Epic, 2nd Gen Centrimag Primary Console, Mitraclip |
| Medtronic, INC. | $1,166.54 | 2021-2025 | Valiant Captivia, Endurant Iis, Trillium Affinity Nt |
| Baxter Healthcare | $851.57 | 2019-2025 | Floseal, Preveleak, Tissue Guard |
| W. L. Gore & Associates, INC. | $658.73 | 2024-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Angiodynamics, INC. | $606.73 | 2022-2025 | Angiovac, Alphavac |
| Becton, Dickinson and Company | $500.00 | 2024 | Hemosphere |
| Kestra Medical Technology Services, INC. | $497.61 | 2023-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $480.93 | 2019-2020 | |
| Philips North America LLC | $306.63 | 2023-2024 | (9520) Igt Devices Undivided, (Bs2) Lm Undivided |
| Artivion, INC. | $294.07 | 2020-2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Intuitive Surgical, INC. | $213.02 | 2019 | |
| Livanova USA, INC. | $133.27 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $111.13 | 2025 | Lynparza |
| Lsi Solutions INC | $105.02 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.91 | 2022-2025 | Lifevest |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Cvrx, INC. | $80.70 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $37.92 | 2025 | Uptravi, Opsumit |
| Haemonetics Corporation | $37.71 | 2022 | |
| Cook Medical LLC | $28.19 | 2024 | Evolution |
| Convatec INC. | $22.19 | 2019 | |
| Boston Scientific Corporation | $20.77 | 2019 | |
| Zimmer Biomet Holdings, INC. | $20.00 | 2019 | |
| Medtronic USA, INC. | $17.27 | 2019 | |
| Empire Medical, INC | $14.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.